Role of the androgen receptor in human breast cancer.

Birrell, S. N.; Hall, R. E.; Tilley, W. D.

doi:10.1023/a:1018730519839

Cited by 124Estrogen and related hormone effectsBreast Cancer Treatment StudiesProstate Cancer Treatment and Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Role of the androgen receptor in human breast cancer.

Birrell, S. N., Hall, R. E., Tilley, W. D.·1998·Journal of Mammary Gland Biology and Neoplasia

DOI 10.1023/a:1018730519839

Open this paper in CoChat — free account

Abstract

Although the androgen receptor (AR)3 is often co-expressed with the estrogen receptor (ER) and progesterone receptor (PR) in human breast tumors, its role in breast cancer is poorly understood. Specific growth stimulatory and inhibitory actions of androgens have been described in human breast cancer cell lines. The mechanisms by which androgens exert these contrasting growth effects are unknown. A commonly utilized second line therapy for the treatment of advanced breast cancer is high dose medroxyprogesterone acetate (MPA). Although MPA, a synthetic progestin, was thought to act exclusively through the PR, the androgenic side-effects observed in women taking MPA suggest that its action may also be mediated in part by the AR. In support of this hypothesis, the level of AR measured by radioligand binding in primary breast tumors was correlated with the duration of response to MPA treatment following failure of tamoxifen therapy. Recent data suggest that the presence of structurally altered AR in breast cancers may account for unresponsiveness to MPA in some of these cases. Further studies are warranted to determine the role of AR mediated pathways in regulating breast tumor growth. In particular, identification of androgen-regulated genes may lead to new possibilities for the hormonal treatment of breast cancer.

Integrity signals

Registry

Crossref · 10.1023/a:1018730519839

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

AR plays a role in the beneficial effects of MPA in breast cancer in women.
“thus suggesting the role of AR in the beneficial effects of MPA in breast cancer in women (246, 247).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [246]

Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
Quigley, C. A., Bellis, A. D., Marschke, K. B., Awady, M. K. E., Wilson, E. M., & French, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,459
Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome
Lubahn, D. B., JOSEPH, D. R., Sullivan, P. M., Willard, H. F., French, F. S., & Wilson, E. M. (1988) · Science · doi:10.1126/science.3353727 · Cited by 1,003
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J. M., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 891
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650
Characterization and expression of a cDNA encoding the human androgen receptor.
Tilley, W. D., Marcelli, M., Wilson, J. D., & McPhaul, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.327 · Cited by 476
Self-citation
Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
Endocrine treatment of breast cancer in women
SANTEN, R. J., MANNI, A., HARVEY, H., & REDMOND, C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-221 · Cited by 399
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
Johnston, S. R. D., Saccani‐Jotti, G., Smith, I. E., Salter, J., Newby, J. C., Coppen, M. J., Ebbs, S. R., & Dowsett, M. (1995) · PubMed · Cited by 301
Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz, K. B., Zava, D. T., Thilagar, A. K., Jensen, E. M., & McGuire, W. L. (1978) · PubMed · Cited by 300
Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.
Kimura, N., Mizokami, A., Oonuma, T., Sasano, H., & Nagura, H. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.5.8468448 · Cited by 298
Androgens induce divergent proliferative responses in human breast cancer cell lines
Birrell, S. N., Bentel, J. M., Hickey, T. E., Ricciardelli, C., Weger, M. A., Horsfall, D. J., & Tilley, W. D. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00005-k · Cited by 245
Self-citation
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
Encarnaci�n, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., & Osborne, C. K. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665801 · Cited by 194
Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats
Chaux, P., Favre, N., Martin, M., & Martin, F. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970807)72:4 · Cited by 185
Multiple estrogen receptor assays in human breast cancer.
Hull, D. F., Clark, G. M., Osborne, C. K., Chamness, G. C., Knight, W. A., & McGuire, W. L. (1983) · PubMed · Cited by 174
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Poulin, R., Baker, D., & Labrie, F. (1988) · Breast Cancer Research and Treatment · doi:10.1007/bf01805942 · Cited by 172
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
Wenger, C. R., Beardslee, S., Owens, M. A., Pounds, G., Oldaker, T. A., Vendely, P., Pandian, M. R., Harrington, D. S., Clark, G. M., & McGuire, W. L. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666351 · Cited by 169
Characterization of progesterone receptor A and B expression in human breast cancer.
Graham, J. D., Yeates, C., Balleine, R. L., Harvey, S. S., Milliken, J. S., Bilous, A. M., & Clarke, C. L. (1995) · PubMed · Cited by 168
A and B forms of the androgen receptor are present inhuman genital skin fibroblasts.
Wilson, C. M., & McPhaul, M. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1234 · Cited by 164
Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors
Isola, J. J. (1993) · The Journal of Pathology · doi:10.1002/path.1711700106 · Cited by 157
Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol
Elo, J. P., Kvist, L. J., Leinonen, K. A., ISOMAA, V. V., Henttu, P. M. A., Lukkarinen, O. A., & Vihko, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530589 · Cited by 143
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers
Pichon, M., Broët, P., Magdelénat, H., Delarue, J., Spyratos, F., Basuyau, J., Saez, S., Rallet, A., Courriere, P. H., Millon, R., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.291 · Cited by 141
Improved measurement of androgen receptors in human breast cancer.
Lea, O. A., Kvinnsland, S., & Thorsen, T. (1989) · PubMed · Cited by 138
Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland, R. L., Hall, R. E., Pang, G. Y. N., Musgrove, E. A., & Clarke, C. L. (1988) · PubMed · Cited by 138
Self-citation
Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis.
Tilley, W. D., Lim-Tio, S. S., Horsfall, D. J., Aspinall, J. O., Marshall, V. R., & Skinner, J. M. (1994) · PubMed · Cited by 131
Self-citation
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.
TORMEY, D. C., LIPPMAN, M. E., EDWARDS, B. K., & CASSIDY, J. G. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-139 · Cited by 128
Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.
POULIN, R., SIMARD, J., LABRIE, C., PETITCLERC, L., DUMONT, M., LAGACÉ, L., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-125-1-392 · Cited by 115
Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
Søreide, J. A., Lea, O. A., Varhaug, J. E., Skarstein, A., & Kvinnsland, S. (1992) · PubMed · Cited by 105
Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.
Teulings, F. A. G., van Gilse, H. A., Henkelman, M. S., Portengen, H., & Alexieva-Figusch, J. (1980) · PubMed · Cited by 103
MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression
Hall, R. E., Birrell, S. N., Tilley, W. D., & Sutherland, R. L. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90424-3 · Cited by 100
Self-citation
Multiple progesterone receptor assays in human breast cancer.
Gross, G. E., Clark, G. M., Chamness, G. C., & McGuire, W. L. (1984) · PubMed · Cited by 95
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
Birrell, S. N., Roder, D. M., Horsfall, D. J., Bentel, J. M., & Tilley, W. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1572 · Cited by 87
Self-citation
Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Poulin, R., Baker, D., Poirier, D., & Labrie, F. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806528 · Cited by 83
Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer
Kuenen‐Boumeester, V., van der Kwast, T., van Putten, W. L. J., Claassen, C., Ooijen, B. V., & Henzen-Logmans, S. C. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520415 · Cited by 83
Androgen sensitivity of the new human breast cancer cell line MFM-223.
Hackenberg, R., Lüttchens, S., Hofmann, J., Kunzmann, R., Hölzel, F., & Schulz, K.-D. (1991) · PubMed · Cited by 76
Multiple actions of synthetic ‘progestins’ on the growth of ZR-75-1 human breast cancer cells: Anin vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids
Poulin, R., Baker, D., Poirier, D., & Labrie, F. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01806369 · Cited by 73
Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.
Dauvois, S., Geng, C.-S., Lévesque, C., Mérand, Y., & Labrie, F. (1991) · PubMed · Cited by 69
Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
Chalbos, D., Haagensen, D. E., Parish, T., & Rochefort, H. (1987) · PubMed · Cited by 66
Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
Hackenberg, R., Hawighorst, T., Filmer, A., Nia, A. H., & Schulz, K.-D. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00689836 · Cited by 57
Untitled work
(1992) · PubMed · Cited by 50
Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast‐cancer cells
Hall, R. E., Tilley, W. D., McPhaul, M. J., & Sutherland, R. L. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520518 · Cited by 48
Self-citation
Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
Sm, T., & Rose, C. (1986) · PubMed · Cited by 47
Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells
Hackenberg, R., Hawighorst, T., Filmer, A., Slater, E. P., Bock, K., Beato, M., & Schulz, K.-D. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90284-p · Cited by 43
Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells
Hackenberg, R., Hofmann, J., H�lzel, F., & Schulz, K. D. (1988) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00398183 · Cited by 42
Estrogen-replacement therapy after breast cancer risks versus benefits
Marchant, D. J. (1993) · Cancer · doi:10.1002/1097-0142(19930315)71:6+ · Cited by 36
Interactions between Estrogens, Androgens, Progestins, and Glucocorticoids in ZR‐75‐1 Human Breast Cancer Cells
Labrie, F., Poulin, R., Simard, J., Zhao, H. F., Labrie, C., Dauvois, S., Dumont, M., Hatton, A.-C., Poirier, D., & Mérand, Y. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34288.x · Cited by 30
Estrogen receptors in androgen-induced breast tumor regression.
Zava, D. T., & McGuire, W. L. (1977) · PubMed · Cited by 28
Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth
Hackenberg, R., Hofmann, J., Wolff, G., Hölzel, F., & Schulz, K. D. (1990) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01613000 · Cited by 26
Affiliations among steroid receptors as revealed by multivariate analysis of steroid binding data
Ojasoo, T., Raynaud, J., & Doré, J. C. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90248-8 · Cited by 18
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer-I. general findings
Lundgren, S., Lønning, P. E., Utaaker, E., Aakvaag, A., & Kvinnsland, S. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90118-c · Cited by 18

Flagged first, then by citations

Research works printed but not linked: 1

S. N. Birrell, J. M. Bentel, D. J. Horsfall, and W. D. Tilley (1996). Androgen receptor expression and medroxyprogeste r-one acetate therapy in human breast cancer. Proc. Amer. Assoc. Cancer Res. 37:237.

Sorted by citations

Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P. J., Bonnefoi, H. R., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G. M., Bergh, J. C. S., Cameron, D., Goldstein, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208561 · Cited by 822
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Robinson, J. L. L., MacArthur, S., Ross-Innes, C. S., Tilley, W. D., Neal, D. E., Mills, I. G., & Carroll, J. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.216 · Cited by 300
Self-citation
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Chmelar, R. S., Buchanan, G., Need, E. F., Tilley, W. D., & Greenberg, N. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 260
Self-citation
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302366 · Cited by 252
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Somboonporn, W., & Davis, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0016 · Cited by 217
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
Gonzalez-Angulo, A. M., Stemke‐Hale, K., Palla, S. L., Carey, M. S., Agarwal, R., Meric-Berstam, F., Traina, T. A., Hudis, C. A., Hortobágyi, G. N., Gerald, W. L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1763 · Cited by 206
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
Lari, S. A., & Kuerer, H. M. (2011) · Journal of Cancer · doi:10.7150/jca.2.232 · Cited by 179
Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
Liao, D. J., & Dickson, R. B. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00185-6 · Cited by 158
Triple-Negative Breast Cancer
Gucalp, A., & Traina, T. A. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181ce4ae1 · Cited by 131
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
Astvatsaturyan, K., Yue, Y., Walts, A. E., & Bose, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197827 · Cited by 127
Expression of androgen receptors in triple negative breast carcinomas
Mrklić, I., Pogorelić, Z., Čapkun, V., & Tomić, S. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.09.006 · Cited by 123
Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual
Burcombe, R. J., Makris, A., Pittam, M. R., & Finer, N. (2003) · The Breast · doi:10.1016/s0960-9776(03)00033-x · Cited by 121
The Role of the Androgen Receptor in Triple-Negative Breast Cancer
Shah, P. D., Gucalp, A., & Traina, T. A. (2013) · Women s Health · doi:10.2217/whe.13.33 · Cited by 121
Evaluation of Prenatal Exposure to Bisphenol Analogues on Development and Long-Term Health of the Mammary Gland in Female Mice
Tucker, D. K., Bouknight, S. H., Brar, S. S., Kissling, G. E., & Fenton, S. E. (2018) · Environmental Health Perspectives · doi:10.1289/ehp3189 · Cited by 117
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Rajagopal, C., Lankadasari, M. B., Aranjani, J. M., & Harikumar, K. B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.034 · Cited by 113
Review of the Etiology of Breast Cancer with Special Attention to Organochlorines as Potential Endocrine Disruptors
Salehi, F., Turner, M. C., Phillips, K. P., Wigle, D. T., Krewski, D. R., & Aronson, K. J. (2008) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400701875923 · Cited by 111
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel, J. M., Birrell, S. N., Pickering, M. A., Holds, D. J., Horsfall, D. J., & Tilley, W. D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00109-4 · Cited by 110
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
Lehmann‐Che, J., Hamy, A., Porcher, R., Barritault, M., Bouhidel, F. A., Habuellelah, H., Leman-Detours, S., de Roquancourt, A., Cahen‐Doidy, L., Bourstyn, E., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3421 · Cited by 110
Breast Cancer in Female-to-Male Transsexuals: Two Cases With a Review of Physiology and Management
Shao, T. H., Grossbard, M. L., & Klein, P. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.06.006 · Cited by 109
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
Birrell, S. N., Butler, L. M., Harris, J. M., Buchanan, G., & Tilley, W. D. (2007) · The FASEB Journal · doi:10.1096/fj.06-7518com · Cited by 90
Self-citation
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element
Lanzino, M., Sisci, D., Morelli, C., Garofalo, C., Catalano, S., Casaburi, I., Capparelli, C., Giordano, C., Giordano, F., Maggiolini, M., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq278 · Cited by 92
Endogenous Coactivator ARA70 Interacts with Estrogen Receptor α (ERα) and Modulates the Functional ERα/Androgen Receptor Interplay in MCF-7 Cells
Lanzino, M., Amicis, F. D., McPhaul, M. J., Marsico, S., Panno, M. L., & Andò, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413576200 · Cited by 89
Targeting the androgen receptor in prostate and breast cancer: several new agents in development
Proverbs-Singh, T. A., Feldman, J. L., Morris, M. J., Autio, K. A., & Traina, T. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0543 · Cited by 90
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma
Riva, C., Dainese, E., Caprara, G., Cossu‐Rocca, P., Massarelli, G., Tot, T., Capella, C., & Eusebi, V. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0003-6 · Cited by 88
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
Pistelli, M., Caramanti, M., Biscotti, T., Santinelli, A., Pagliacci, A., Lisa, M. D., Ballatore, Z., Ridolfi, F., Maccaroni, E., Bracci, R., et al. (2014) · Cancers · doi:10.3390/cancers6031351 · Cited by 88
Targeting the androgen receptor in triple-negative breast cancer
Gucalp, A., & Traina, T. A. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2016.09.004 · Cited by 87
High frequency of skewed X inactivation in young breast cancer patients
Kristiansen, M. B., Langerød, A., Knudsen, G. P., Weber, B. L., Børresen-Dale, A.-L., & Ørstavik, K. H. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.30 · Cited by 86
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells
Graham, T. R., Yacoub, R., Taliaferro-Smith, L. D., Osunkoya, A. O., Odero-Marah, V., Liu, T., Kimbro, K. S., Sharma, D., & O'Regan, R. M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0623-7 · Cited by 83
BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription
Shin, S., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1132020100 · Cited by 80
17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production
Aka, J. A., Mazumdar, M., Chen, C., Poirier, D., & Lin, S. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0468 · Cited by 80
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
Cops, E. J., Bianco‐Miotto, T., Moore, N. L. T., Clarke, C. L., Birrell, S. N., Butler, L. M., & Tilley, W. D. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.014 · Cited by 76
Self-citation
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
Ricciardi, G. R. R., Adamo, B., Ieni, A., Licata, L., Cardia, R., Ferraro, G., Franchina, T., Tuccari, G., & Adamo, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128368 · Cited by 73
The androgen receptor CAG repeat: a modifier of carcinogenesis?
Ferro, P., Catalano, M. G., Dell’Eva, R., Fortunati, N., & Pfeffer, U. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00104-1 · Cited by 73
Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate
Buchanan, G., Birrell, S. N., Peters, A. A., Bianco‐Miotto, T., Ramsay, K., Cops, E. J., Yang, M., Harris, J. M., Simila, H. A., Moore, N. L. T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3077 · Cited by 68
Self-citation
The role of androgen receptor in breast cancer
Iacopetta, D., Rechoum, Y., & Fuqua, S. A. W. (2012) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2012.11.003 · Cited by 67
Androgen Receptor As A Target For the Treatment of Hormone Receptor-Negative Breast Cancer: An Unchartered Territory
Nahleh, Z. A. (2008) · Future Oncology · doi:10.2217/14796694.4.1.15 · Cited by 67
Differential Effects of Exogenous Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary Gland
Peters, A. A., Ingman, W. V., Tilley, W. D., & Butler, L. M. (2011) · Endocrinology · doi:10.1210/en.2011-1133 · Cited by 64
Self-citation
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast
Hanley, K. Z., Wang, J., Bourne, P. A., Yang, Q., Gao, A. C., Lyman, G. H., & Tang, P. T. P. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.07.007 · Cited by 62
Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer
Menin, C., Banna, G. L., Salvo, G. L. D., Lazzarotto, V., Nicolo, A. D., Agata, S., Montagna, M., Sordi, G., Nicoletto, O., Chieco‐Bianchi, L., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00473-6 · Cited by 58
Steroid receptors in human breast tumorigenesis and breast cancer progression.
Murphy, L., & Watson, P. (2002) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/s0753-3322(01)00157-3 · Cited by 59
Androgen receptor: A promising therapeutic target in breast cancer
Vasiliou, S. K., & Diamandis, E. P. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1575643 · Cited by 52
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
Yousef, G. M., Scorilas, A., Magklara, A., Memari, N., Ponzone, R., Sismondi, P., Biglia, N., Ellatif, M. E. A., & Diamandis, E. P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600590 · Cited by 48
The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer
Yousef, G. M., Scorilas, A., Nakamura, T., Ellatif, M. E. A., Ponzone, R., Biglia, N., Maggiorotto, F., Roagna, R., Sismondi, P., & Diamandis, E. P. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1022931403825 · Cited by 47
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
Pandrangi, S. L., Bagadi, S. A. R., Sinha, N. K., Kumar, M., Dada, R., Lakhanpal, M., Soni, A., Malvia, S., Simon, S., Chintamani, C., et al. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-14 · Cited by 46
Androgen receptor status in female breast cancer: RT-PCR and Western blot studies
Bryś, M., Wójcik, M., Romanowicz‐Makowska, H., & Krajewska, W. M. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320100294 · Cited by 45
Post-menopausal breast cancer: from estrogen to androgen receptor
Majumder, A., Singh, M., & Tyagi, S. C. (2017) · Oncotarget · doi:10.18632/oncotarget.22156 · Cited by 41
Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer
Aka, J. A., Mazumdar, M., & Lin, S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.042 · Cited by 42
Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions
Dessauvagie, B. F., Zhao, W., Fuller, K. A., Harvey, J. M., & Bentel, J. M. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.08.003 · Cited by 40
Pushing estrogen receptor around in breast cancer
Lim, E., Tarulli, G. A., Portman, N., Hickey, T. E., Tilley, W. D., & Palmieri, C. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0427 · Cited by 40
Self-citation
Dehydroepiandrosterone, androgens and the mammary gland
Labrie, F. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600624440 · Cited by 39
Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER−, PR−, AR+ breast cancer
Lyu, S., Yu, Q., Ying, G., Wang, S., Wang, Y., Zhang, J., & Niu, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2151 · Cited by 37
Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects
Yeh, Y., Chang, C.-W., Wei, R., & Wang, S. (2013) · BioMed Research International · doi:10.1155/2013/290575 · Cited by 37
Role of androgens in proliferation and differentiation of mouse mammary epithelial cell line HC11
Baratta, M., Grolli, S., Poletti, A., Ramoni, R., Motta, M., & Tamanini, C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670053 · Cited by 37
Non‐competitive steroid inhibition of oestrogen receptor functions
Puddefoot, J. R., Barker, S., Glover, H. R., Malouitre, S. D. M., & Vinson, G. P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10547 · Cited by 37
Coexpression of Androgen Receptor and FOXA1 in Nonmetastatic Triple-Negative Breast Cancer: Ancillary Study from PACS08 Trial
Guiu, S., Charon‐Barra, C., Vernerey, D., Fumoleau, P., Campone, M., Spielmann, M., Roche, H. H., Mesleard, C., Arnould, L., Lemonnier, J., et al. (2015) · Future Oncology · doi:10.2217/fon.15.102 · Cited by 36
Mammary growth hormone and tumorigenesis – lessons from the dog
Mol, J. A., Leeuwen, I. S. L., van Garderen, E., Selman, P. J., Oosterlaken-Dijksterhuis, M. A., Schalken, J. A., & Rijnberk, A. (1999) · Veterinary Quarterly · doi:10.1080/01652176.1999.9695004 · Cited by 36
Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
Liede, A., Zhang, W., Matsuda, M. L. D. L., Tan, A., & Narod, S. A. (2003) · PubMed · Cited by 35
The Androgen Receptor: Structure, Mutations, and Antiandrogens
Hirawat, S., Budman, D. R., & Kreis, W. (2003) · Cancer Investigation · doi:10.1081/cnv-120018232 · Cited by 34
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion
Peng, Y., Li, Y., Gellert, L. L., Zou, X., Wang, J., Singh, B., Xu, R., Chiriboga, L. A., Daniels, G., Pan, R., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00936.x · Cited by 32
Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation
Lapointe, J., & Labrie, C. (2001) · Endocrinology · doi:10.1210/endo.142.10.8417 · Cited by 30
Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
Agrawal, A. K., Ziolkowski, P. P., Grzebieniak, Z., Jeleń, M., Bobinski, P., & Agrawal, S. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000234 · Cited by 29
Hormone replacement therapy (HRT), breast cancer and tumor pathology
Dietel, M. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.11.005 · Cited by 27
Progestin-induced Mammary Growth Hormone (GH) Production
Mol, J. A., Leeuwen, I. S. L., van Garderen, E., & Rijnberk, A. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_8 · Cited by 27
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+ progenitor/amplified cells and pre‐malignant lesions and invasive disease
Celis, J. E., Gromova, I., Cabezón, T., Gromov, P., Shen, T., Wielenga, V. T., Rank, F. E., & Moreira, J. M. A. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.09.004 · Cited by 26
Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
Hietala, M., Sandberg, T., Borg, Å., Olsson, H. L., & Jernström, H. (2006) · Human Reproduction · doi:10.1093/humrep/del318 · Cited by 26
Pesticide Exposure and Head and Neck Cancers: A Case-Control Study in an Agricultural Region.
Amizadeh, M., Safari-Kamalabadi, M., Askari-Saryazdi, G., Amizadeh, M., & Reihani‐Kermani, H. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijorl.2017.20786.1692 · Cited by 25
Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer
Martín-Ruiz, A., Peña, L., Gil, A. G., Díez, L., Cáceres, S., & Illera, J. C. (2018) · BMC Cancer · doi:10.1186/s12885-018-4518-z · Cited by 25
Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability
Ferro, P., Catalano, M. G., Raineri, M., Reato, G., Dell’Eva, R., Risio, M., Foà, R., Fortunati, N., & Pfeffer, U. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00296-x · Cited by 25
Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors
Berns, E. M. J. J., Dirkzwager-Kiel, M. M., Kuenen‐Boumeester, V., Timmermans, M. A. M., Verhoog, L. C., van den Ouweland, A. M. W., Meijers-Heijboer, H. E. J., Klijn, J. G. M., & van der Kwast, T. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023347409599 · Cited by 25
Androgen receptor antagonists: a patent review (2008 – 2011)
Mohler, M. L., Coss, C. C., Duke, C. B., Patil, S. A., Miller, D. D., & Dalton, J. T. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.682571 · Cited by 25
Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort
Elebro, K., Butt, S. T., Dorkhan, M., Jernström, H., & Borgquist, S. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0394-2 · Cited by 22
Conjugated and non-conjugated androgens differentially modulate specific early gene transcription in breast cancer in a cell-specific manner
Notas, G., Pelekanou, V., Castanas, E., & Kampa, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.10.004 · Cited by 21
Recent advances in breast cancer biology
Schultz, L. B., & Weber, B. L. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00002 · Cited by 21
Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog
Marinelli, L., Gabai, G., Wolfswinkel, J., & Mol, J. A. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.08.001 · Cited by 20
Aromatase Inhibitors and Inactivators for Breast Cancer Therapy
Lønning, P. E. (2002) · Drugs & Aging · doi:10.2165/00002512-200219040-00003 · Cited by 20
Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.
Mishra, A. K., Agrawal, U., Negi, S., Bansal, A., Mohil, R. S., Chintamani, C., Bhatnagar, A., Bhatnagar, D., & Saxena, S. (2012) · Europe PMC (PubMed Central) · Cited by 19
Are there CAG repeat expansion-related disorders outside the central nervous system?
Ferro, P., Dell’Eva, R., & Pfeffer, U. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00663-3 · Cited by 19
Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro
Thomas, L. N., Chedrawe, E. R., Barnes, P. J., & Too, C. K. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4223-7 · Cited by 17
Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
Ismael, N. E. H. S., Khairy, R. A., Talaat, S. M., & El-Fattah, F. A. A. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.311 · Cited by 16
Role of pocket flexibility in the modulation of estrogen receptor alpha by key residue arginine 394
Mu, Y., Peng, S., Zhang, A., & Wang, L. (2010) · Environmental Toxicology and Chemistry · doi:10.1002/etc.389 · Cited by 13
Correlation between estrogen receptor, progesterone receptor, HER-2/neu status and other prognostic factors in carcinoma breast in Indian population
Manuneethimaran, T., Navrathan, N., Mohanapriya, T., Kumar, A., & Singh, B. K. (2015) · International Surgery Journal · doi:10.18203/2349-2902.isj20151000 · Cited by 13
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention
Jinna, N., Jovanović‐Talisman, T., LaBarge, M. A., Natarajan, R. D., Kittles, R. A., Sistrunk, C., Rida, P. C. G., & Seewaldt, V. L. (2022) · Cancers · doi:10.3390/cancers14184484 · Cited by 16
In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines
Cáceres, S., Monsalve, B., Peña, L., de Andrés, P. J., Alonso‐Diez, Á., Illera, M. J., Woodward, W. A., Reuben, J., Silván, G., & Illera, J. C. (2017) · Veterinary and Comparative Oncology · doi:10.1111/vco.12324 · Cited by 13
Systematic identification of transcription factors associated with patient survival in cancers
Cheng, C., Li, L. M., Alves, P., & Gerstein, M. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-225 · Cited by 12
Prolactin/Stat5 and Androgen R1881 Coactivate Carboxypeptidase-D Gene in Breast Cancer Cells
Koirala, S., Thomas, L. N., & Too, C. K. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1202 · Cited by 12
Establishment and characterization of a canine xenograft model of inflammatory mammary carcinoma
Camacho, L., Peña, L., Gil, A. G., Cáceres, S., Díez, L., & Illera, J. C. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.07.017 · Cited by 11
The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells
Ahram, M. A., Mustafa, E. H., Hammad, S. A., Alhudhud, M., Bawadi, R., Tahtamouni, L. H., Khatib, F. A., & Zihlif, M. (2018) · Endocrine Research · doi:10.1080/07435800.2018.1455105 · Cited by 11
Effect of AR antagonist combined with PARP1 inhibitor on sporadic triple-negative breast cancer bearing AR expression and methylation-mediated BRCA1 dysfunction
Sang, M., Lc, M., Ma, C., Liu, S. L., Sang, M., Chang, S., Liu, F., Lian, Y., & Geng, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.136 · Cited by 11
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)
Yardley, D. A., Young, R. R., Adelson, K. B., Silber, A. L. M., Najera, J. E., Daniel, D. B., Peacock, N. W., Finney, L. H., Hoekstra, S., Shastry, M., et al. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.10.011 · Cited by 11
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Zagouri, F., Ψαλτοπούλου, Θ., Giannos, A., Filipits, M., Brandstetter, A., Tsigginou, A., Sotiropoulou, M. G., Papaspyrou, I., Sergentanis, T. Ν., Rodolakis, A., et al. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s78254 · Cited by 11
ERK/MAPK Regulation of the Androgen Responsiveness of Breast Cancer Cells
Azzam, D., Tay, J. W. T., Greeve, M. A., Harvey, J. M., & Bentel, J. M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_41 · Cited by 11
Tibolone and 5α-dihydrotestosterone alone or in combination with an antiandrogen in a rat breast tumour model
Deckers, G. H., Verheul, H. A. M., van Aalst, G. B. T., Cremers, E. A. M., de Gooyer, M. E., & Kloosterboer, H. J. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00391-4 · Cited by 9
Androgen Receptor Expression in Breast Carcinoma of Egyptian Patients
Samaka, R. M. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/23364.8919 · Cited by 8
Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma
Sajadieh, S. S., Mohammadizadeh, F., Sajjadieh, H., & Kasaei, Z. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.133260 · Cited by 8
Effects of dihydrotestosterone on gene expression in mammary gland
Aboghe, D. H., Bolduc, C., Yoshioka, M., & St‐Amand, J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.006 · Cited by 7
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Mishra, A., Mishra, S. K., Sharanappa, V., Krishnani, N., Kumari, N., & Agarwal, G. (2024) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-024-01877-2 · Cited by 6
Does Androgen Receptor Have a Prognostic Role in Patients with Estrogen/Progesterone-Negative and c-erbB-2-Positive Breast Cancer?
Arslan, Ç., Işık, M., Güler, G., Kulaç, İ., Solak, M., Türker, B., Ozisik, Y. Y., & Altundağ, K. (2012) · The American Surgeon · doi:10.1177/000313481207800941 · Cited by 6
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer
Li, H., Song, G., Zhou, Q., Ran, R., Jiang, H., Zhang, R., Liu, Y., Zhang, J., Meng, L., Ma, L., et al. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06345-x · Cited by 6
Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families
Hietala, M., Henningson, M., Törngren, T., Olsson, H. L., & Jernström, H. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.09.006 · Cited by 5

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel, J. M., Birrell, S. N., Pickering, M. A., Holds, D. J., Horsfall, D. J., & Tilley, W. D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00109-4 · Cited by 110
Self-citation
The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology
Bleach, R., & McIlroy, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00594 · Cited by 71
Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate
Buchanan, G., Birrell, S. N., Peters, A. A., Bianco‐Miotto, T., Ramsay, K., Cops, E. J., Yang, M., Harris, J. M., Simila, H. A., Moore, N. L. T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3077 · Cited by 68
Self-citation
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
Birrell, S. N., Roder, D. M., Horsfall, D. J., Bentel, J. M., & Tilley, W. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1572 · Cited by 87
Self-citation
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
Lim, E., Hickey, T. E., Selth, L. A., Chia, K. M., Milioli, H. H., Roden, D. L., Laven‐Law, G., Jindal, S., Hui, M. N., Ebrahimie, E., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.sabcs19-gs2-03
Self-citation

Authors: Birrell, S. N., Hall, R. E., & Tilley, W. D.
Affiliations: Flinders University (AU)
ORCID: Birrell, S. N.
Tilley, W. D.
Venue: Journal of Mammary Gland Biology and Neoplasia
Publisher: Springer Science and Business Media LLC
Published: 1998-01
Volume: 3
Issue: 1
Pages: 95-103
ISSN: 1083-3021 (ISSN-L)
1573-7039
DOI: 10.1023/a:1018730519839
OpenAlex: W1578641183
Cited by: 124
References: 50
Citations by year: 2024: 3 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 7 · 2013: 6 · 2012: 7
FWCI: 1.71
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Journal of Mammary Gland Biology and Neoplasia (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords: androgen receptor, breast cancer, medroxyprogesterone acetate, progestin resistance, tamoxifen resistance, androgen-regulated genes, hormone therapy, androgen receptor mutations, tumor growth control, estrogen receptor, progesterone receptor
MeSH terms: Breast Neoplasms, Female, Humans, Receptors, Androgen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of the androgen receptor in human breast cancer.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks